AzTrials
AzTrials

Intracranial Pressure IncreaseNCT05931991

Intra-operative Evaluation of the External Ventricular Drain Catheter Position With Structured Light for Patients (Bullseye EVD)

An observational study of Intracranial Pressure Increase, run by Sunnybrook Health Sciences Centre at 1 site in Canada.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

The placement of external ventricular drainage (EVD) is a life-saving procedure used to relieve high pressures in the brain. Often performed at the bedside, a small tube (catheter) is inserted into one ventricle of the brain to drain cerebrospinal fluid and release the pressure build up. Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Intracranial Pressure Increase
How many people
15 participants
Where
1 siteCanada
Study dates
7 Jul 2023to Nov 2025
How long will I take part?
1 Day
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Study population: A total of 15 patients will be enrolled in this study at Sunnybrook Health Sciences Centre's ICU. The PI, study team members who are part of the circle of care, and study personnel will identify potential study participants. The Research Coordinator or assistant will approach for consent. Given that the clinical procedure involved- the EVD- is an urgent procedure with short timelines, s deferred consent model may also be used in this study as it satisfies the conditions for deferred consent as set out in the Tri-Council Policy Statement: Ethical Conduct for Research Involving Humans - TCPS 2 (2022) Article 3.7A,.

Who may be able to join

  • ≥18 years of age
  • Scheduled to undergo placement of an EVD
  • Located in B5 ICU or CRCU
  • Existing pre-procedural head CT imaging

Who cannot join

  • 1. Set up time poses a safety risk (Clinical discretion)

Trial locations and contacts

1 site in 1 country.

Canada1 site, 1 recruiting
  • Sunnybrook Health Sciences Centre

    Toronto, Ontario, M4N 3M5

    Cari Whyne, PhD, 4164806100 ext. 5056, cwhyne@sri.utoronto.ca

    Layla Pires, laylabtu@gmail.com

    Recruiting

Other trials in Canada

About this study

Official title: Intra-operative Evaluation of the External Ventricular Drain Catheter Position With Structured Light

The placement of external ventricular drainage (EVD) is a life-saving procedure used to relieve high pressures in the brain. Often performed at the bedside, a small tube (catheter) is inserted into one ventricle of the brain to drain cerebrospinal fluid and release the pressure build up. In standard practice, EVDs are placed freehand and initial catheter malpositioning occurs in up to ~60% of procedures. Currently, there are no adequate means to verify the position of the catheter before insertion which is a significant impediment to ensure accurate positioning. This non-interventional study aims to validate a novel technology, Bullseye EVD, for verifying the position of the EVD catheter during these emergency procedures.

Read the detailed description

External ventricular drainage (EVD) is a life-saving procedure used to release cerebrospinal fluid and relieve elevated intracranial pressure due to acute hydrocephalus, often secondary to subarachnoid hemorrhage, spontaneous intracerebral hemorrhage or traumatic brain injury (TBI). To drain cerebrospinal fluid (CSF) from the ventricular system and relieve pressure on the brain, a catheter is inserted into the ipsilateral frontal horn of the lateral ventricle (IFHLV) close to the Foramen of Monro (FoM). Twist-drill trephination is utilized to create a frontal burr hole at Kocher's point, approximately 11.5cm superior to the nasion and 2-3cm lateral of the midline. The dura is perforated, and the catheter is inserted with a rigid stylus. The current standard of care is a freehand technique which is often performed by neurosurgeons at the bedside in the ICU. It relies on surface anatomical landmarks to guide the catheter trajectory towards the FoM perpendicular to the calvarial slope at Kocher's point. However, the freehand technique is challenging to accurately perform, often requiring multiple passes of the catheter through the brain, with trajectory deviation most critical to malpositioning. Up to 24% of malpositioned EVDs require revision or reinsertion which can significantly increase catheter-associated infection. Up to 45.5% of EVD procedures require multiple passes for successful catheter insertion (6). This can lead to hemorrhage along the catheter tract (up to 34%, catheter dysfunction (up to 38%, and catheter-associated infection (up to 36% which increase EVD-associated health care costs (up to 20%). EVD malpositioning outside of the IFHLV (up to 60%) has been associated with other rare but significant complications including coma and diabetes insipidus. Large deviations in catheter placement have resulted in catheter insertion into significant brain regions (thalamus, hypothalamus, basal ganglion, internal capsule. Angular error within the coronal plane is the primary determinant of successful catheter insertion.

Bullseye is a novel intra-procedural system the investigators initially developed for glenoid guidepin placement. Bullseye EVD uses a verification workflow (guess and check) to identify EVD catheter position and trajectory with reference to the diagnostic CT image prior to catheter insertion using structured-light imaging. Structured-light scanning currently has several medical applications due to its speed, accuracy, and robust 3D surface reconstruction, and has been investigated in planning bedside subdural evacuation port system placement. In vitro performance of Bullseye EVD was demonstrated through testing on 3 cadaveric specimens to localize EVD placement on both sides of each of the heads (N=6 trials in total). The success of this in vitro work motivated further development of the technology including clinical evaluation for EVD.

Reducing EVD malpositioning and associated complications is a priority for neurosurgeons, however costly and cumbersome navigation solutions have had limited uptake in this urgent procedure that is often conducted at the bedside. Bullseye EVD represents a portable, safe, low-cost technology that can identify catheter positioning on existing preprocedural CT imaging. The proposed work, including integration into the existing clinical workflow, evaluation of in vivo accuracy and automation to enable rapid feedback during EVD placement, is critical to translating this technology from the bench to the bedside.

Keywords
External Ventricular Drain, Intracranial Pressure, EVD malpositioning
Medical subject headings
Intracranial Hypertension

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Accuracy of the structured light computer vision system

    The primary study outcome will be the accuracy of the structured light computer vision system. This will be quantified as the difference between predicted and actual position of the EVD catheter measured as a combined analysis of version error (degrees), inclination error (degrees), and offset error (mm).

    Measured: Data analysis to start immediately post procedure.

Secondary outcomes (3)
  1. Procedural time for Fiducial placement and optical imaging

    The number of minutes required for these additional tasks

    Measured: Time measured during procedure

  2. Workflow integration

    Analysis of the current workflow and changes required to enable the use of Bullseye EVD

    Measured: Immediately after procedure

  3. User feedback

    User feedback to evaluate acceptability and utility of the technology by the surgeons and procedural team, and to identify potential barriers and opportunities to improve safe and accurate EVD placement. This will be conducted within a user centred design framework

    Measured: Immediately after procedure

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted6 Jul 2023
  2. Study start7 Jul 2023
  3. Primary completionMar 2025 (estimated)
  4. Study completionNov 2025 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Case only
Time perspective
Prospective
Enrolment
15 participants (estimated)
Target duration
1 Day
IDs, dates and publications
ClinicalTrials.gov ID
NCT05931991
Sponsor's protocol ID
Bullseye EVD
Status last verified
May 2024
First submitted
31 May 2023
Last updated
9 May 2024
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

An observational study of Intracranial Pressure Increase, run by Sunnybrook Health Sciences Centre at 1 site in Canada.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 9 May 2024. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Canada. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Cari Whyne, PhD, FIOR (416-480-6100 ext. 65056, cari.whyne@sunnybrook.ca), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Accuracy of the structured light computer vision system (time frame: Data analysis to start immediately post procedure.). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 9 May 2024.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in